Patent details

EP1274427 Title: FORMULATION OF SUBSTITUTED BENZIMIDAZOLES

Basic Information

Publication number:
EP1274427
PCT Application Number:
PCT/SE/2000/001992
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009732959
PCT Publication Number:
WO/2001/028558
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATION OF SUBSTITUTED BENZIMIDAZOLES
French Title of Invention:
FORMULATIONS DE BENZIMIDAZOLES SUBSTITUES
German Title of Invention:
ZUSAMMENSETZUNG DIE SUBSTITUIERTE BENZIMIDAZOLE ENTHÄLT
SPC Number:

Dates

Filing date:
13/10/2000
Grant date:
21/09/2005
EP Publication Date:
21/09/2005
PCT Publication Date:
26/04/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/01/2003
EP B1 Publication Date:
21/09/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/10/2012
Expiration date:
13/10/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/10/2000
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
24/10/2005
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

Name:
BRÜLLS Mikael
Address:
Sweden (SE)

Priority

Priority Number:
9903831
Priority Date:
22/10/1999
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 31/44;
Filing date Document type Number of pages